Annexin A2 inhibition suppresses ovarian cancer progression via regulating β-catenin/EMT

  • Authors:
    • Yan Liu
    • Hongyu Li
    • Zhenying Ban
    • Manman Nai
    • Li Yang
    • Yannan Chen
    • Yiming Xu
  • View Affiliations

  • Published online on: April 18, 2017     https://doi.org/10.3892/or.2017.5578
  • Pages: 3643-3650
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Annexin A2 is a member of the Annexin family that acts as a Ca2+-dependent phospholipid and membrane binding protein, which is associated with the survival and spread of multiple neoplasms. However, the function of Annexin A2 in ovarian cancer progression remains unclear. In this study, we aimed to investigate the role and underlying molecular mechanism of Annexin A2 in cell proliferation and invasion in ovarian cancer. We found that the mRNA expression of Annexin A2 was upregulated in ovarian cancer tissues and cell lines. In the loss-of-function of Annexin A2, β-catenin was indicated to be significantly suppressed and EMT constrained. Moreover, cell proliferation and invasion were both markedly inhibited by the downregulation of Annexin A2. Additionally, the overexpression of β-catenin obviously reversed the effect of Annexin A2 on EMT, and cell proliferation and invasion, indicating that Annexin A2 suppression regulated EMT through controlling β-catenin. Taken together, this study showed that Annexin A2 inhibition suppresses proliferation and invasion in ovarian cancer via β-catenin/EMT, proposing the potential role of Annexin A2 in the prevention and treatment of ovarian cancer.
View Figures
View References

Related Articles

Journal Cover

June-2017
Volume 37 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu Y, Li H, Ban Z, Nai M, Yang L, Chen Y and Xu Y: Annexin A2 inhibition suppresses ovarian cancer progression via regulating β-catenin/EMT. Oncol Rep 37: 3643-3650, 2017.
APA
Liu, Y., Li, H., Ban, Z., Nai, M., Yang, L., Chen, Y., & Xu, Y. (2017). Annexin A2 inhibition suppresses ovarian cancer progression via regulating β-catenin/EMT. Oncology Reports, 37, 3643-3650. https://doi.org/10.3892/or.2017.5578
MLA
Liu, Y., Li, H., Ban, Z., Nai, M., Yang, L., Chen, Y., Xu, Y."Annexin A2 inhibition suppresses ovarian cancer progression via regulating β-catenin/EMT". Oncology Reports 37.6 (2017): 3643-3650.
Chicago
Liu, Y., Li, H., Ban, Z., Nai, M., Yang, L., Chen, Y., Xu, Y."Annexin A2 inhibition suppresses ovarian cancer progression via regulating β-catenin/EMT". Oncology Reports 37, no. 6 (2017): 3643-3650. https://doi.org/10.3892/or.2017.5578